Cybin Inc (CYBN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CYBN | NVCT | ATHA | ||
Company | Cybin Inc | Nuvectis Pharma Inc | Athira Pharma Inc | ||
Price Information | |||||
Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
Open | 0.2974 | 6.81 | 3.12 | ||
High | 0.3000 | 6.82 | 3.24 | ||
Low | 0.2600 | 6.56 | 3.06 | ||
Last | 0.2849 | 6.74 | 3.24 | ||
Change | -0.0150 | +0.02 | +0.13 | ||
% Change | -5.00% | +0.30% | +4.18% | ||
Volume | 6,076,660 | 15,561 | 86,495 | ||
20-Day Average Volume | 5,543,572 | 110,979 | 143,251 | ||
Previous Close | 0.2999 | 6.72 | 3.11 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.2811 | 6.53 | 2.90 | ||
20-Day Raw Stochastic | 39.32% | 47.18% | 75.51% | ||
20-Day Relative Strength | 43.56% | 50.66% | 61.18% | ||
Weighted Alpha | -47.60 | -58.34 | +20.28 | ||
Today's Opinion | 72% Sell | 48% Sell | 88% Buy | ||
Previous Opinion | 72% Sell | 48% Sell | 88% Buy | ||
Last Month's Opinion | 100% Sell | 72% Sell | 48% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -13.11% since 07/15/24 | +0.30% since 07/15/24 | -3.57% since 07/15/24 | ||
Low | 0.2600 on 07/22/24 | 6.45 on 07/18/24 | 3.06 on 07/22/24 | ||
High | 0.3282 on 07/16/24 | 7.01 on 07/16/24 | 3.44 on 07/18/24 | ||
1-Month | |||||
%Chg | +6.93% since 06/21/24 | -5.39% since 06/21/24 | +38.46% since 06/21/24 | ||
Low | 0.2475 on 07/08/24 | 6.00 on 06/28/24 | 2.13 on 06/25/24 | ||
High | 0.3360 on 07/15/24 | 7.42 on 06/26/24 | 3.60 on 07/15/24 | ||
3-Month | |||||
%Chg | -21.67% since 04/22/24 | -6.06% since 04/22/24 | +55.02% since 04/22/24 | ||
Low | 0.2475 on 07/08/24 | 5.85 on 05/20/24 | 1.89 on 04/25/24 | ||
High | 0.3800 on 05/10/24 | 8.45 on 05/06/24 | 3.60 on 07/15/24 | ||
6-Month | |||||
%Chg | -25.71% since 01/22/24 | -6.45% since 01/22/24 | +5.54% since 01/22/24 | ||
Low | 0.2475 on 07/08/24 | 5.85 on 05/20/24 | 1.89 on 04/25/24 | ||
High | 0.5224 on 03/13/24 | 12.10 on 03/14/24 | 4.30 on 02/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 123,215 | 123,352 | 119,203 | ||
Shares Outstanding, K | 410,855 | 18,356 | 38,329 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -57,880,000 | -22,260,000 | -117,670,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -15,950,000 | -4,170,000 | -26,340,000 | ||
60-Month Beta | 0.43 | 0.46 | 2.90 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.04 on 06/26/24 | -0.25 on 05/07/24 | -0.69 on 05/15/24 | ||
Latest Earnings Date | 08/12/24 | 08/14/24 | 08/08/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |